Last update 31 May 2025

Pacibekitug

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
PF 4236921, PF-4236921, TOUR-006
Target
Action
inhibitors
Mechanism
IL-6 inhibitors(Interleukin-6 inhibitors)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 2
United States
15 May 2024
Graves OphthalmopathyPhase 2
United States
19 Feb 2024
Graves OphthalmopathyPhase 2
Canada
19 Feb 2024
Graves OphthalmopathyPhase 2
Jordan
19 Feb 2024
Graves OphthalmopathyPhase 2
New Zealand
19 Feb 2024
Graves OphthalmopathyPhase 2
Spain
19 Feb 2024
Crohn DiseasePhase 2
United States
01 Feb 2011
Crohn DiseasePhase 2
Australia
01 Feb 2011
Crohn DiseasePhase 2
Belgium
01 Feb 2011
Crohn DiseasePhase 2
Brazil
01 Feb 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
Pacibekitug 25 mg quarterly
eohbxpbmkz(jsgiqzgobz) = sjoyxdeosi mjkrmedyls (izljcxmwof )
Positive
20 May 2025
Pacibekitug 50 mg quarterly
eohbxpbmkz(jsgiqzgobz) = casfakdvbr mjkrmedyls (izljcxmwof )
Phase 2
191
PF-04236921
wfaeddezqc = hctmdebviw tgdahzvsbg (nrnoyzccyl, esybmqqrzl - zddddfdosz)
-
20 Mar 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free